Accord Healthcare UK Ltd are a young yet dynamic pharmaceutical company. They develop, manufacture and distribute pharmaceutical products to over 70 countries across the globe.
They are one of the fastest growing generic pharmaceutical companies in the UK & Ireland. They have one of the most extensive sales, marketing and distribution networks in Europe.
Headquartered in the UK, Accord now supplies products to close to 65 EMENA markets.
Their vision is to be involved and make an impact in all aspects of bringing pharmaceuticals to patients.
Accord currently have a portfolio comprising of nearly 7000 product approvals in Europe. They operate a pan European commercial footprint with a direct presence in all the major EU markets.
Award Winners 2020
Accord Healthcare was the most recognised company at the Global Generics & Biosimilar Awards 2020. After having won the award for Company of the Year. They then went to also collect the ‘Regulatory Achievement of the Year’ and ‘Corporate Responsibility Initiative of the Year’ Awards also.
These awards are renowned for rewarding ‘best practice’ in the industry, while at the same time encouraging improvements in every aspect of the way business is conducted.
Accord Healthcare UK Ltd, Intas Pharmaceuticals and Lambda Research were honoured to be on the shortlist. In not just one, but in all of the categories entered at The Global Generics & Biosimilars Awards 2020. Which took place on Tuesday the 3 November.
Accord’s vision is to become a leading pan-EMENA generics company by 2021 (this year). They also aim to have developed a specialty products commercialisation capability within this annum also.